A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Clinical trial NCT06999187 · RECRUITING

Trial details

NCT number: NCT06999187
Sponsor: Dren Bio
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer HER2-negative Breast Cancer Non Small Cell Lung Cancer Cervical Cancer Castrate Resistant Prostate Cancer Pancreatic Ductal Adenocarcinoma Head-and-neck Squamous Cell Carcinoma Endometrial Cancer Ovarian Cancer Gastric Cancer Gastroesophageal-junction Cancer Urothelial Carcinoma

Start date: 2025-06-03
Primary completion: 2027-07-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.